Literature DB >> 29762383

Starch Tolerance and the Short Bowel.

Jan de Laffolie1, Hassan Y Naim2, Silvia Rudloff1, Klaus-Peter Zimmer1.   

Abstract

Short bowel syndrome with intestinal failure is a rare disease with a massive impairment in quality of life, requiring a multidisciplinary team approach to medical, surgical, and nutritional therapy. Current pharmacological and surgical therapeutic options are limited; an important cornerstone is enteral and parenteral nutrition. The changed physiology of carbohydrate digestion plays a major role in the adaptation process and can be a target for specific enteral nutrition interventions. An important prognostic factor is the preservation of at least portions of the colon in continuity with small bowel. This strategy has to include an evaluation of the anatomical situation and small bowel absorptive capacity, adaptation processes, and luminal microbiota including its fermentative properties. Starch is probably the most important complex carbohydrate in short bowel syndrome nutrition, because it is absorbed or fermented almost completely. Benefits of supplementation with complex carbohydrates include improved adaptive processes, positive trophic effects on the mucosa and its hormonal response, longer transit time, and possibly a faster time to wean from parenteral nutrition, but supplementation advice needs to weigh carefully the risks and benefits, especially considering bacterial overgrowth, osmotic load, and D-lactate acidosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762383     DOI: 10.1097/MPG.0000000000001962

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  2 in total

Review 1.  Nutritional and pharmacological strategy in children with short bowel syndrome.

Authors:  Michael E Höllwarth; Valeria Solari
Journal:  Pediatr Surg Int       Date:  2021-01-03       Impact factor: 1.827

2.  A reduced-carbohydrate and lactose-free formulation for stabilization among hospitalized children with severe acute malnutrition: A double-blind, randomized controlled trial.

Authors:  Robert H J Bandsma; Wieger Voskuijl; Emmanuel Chimwezi; Greg Fegan; André Briend; Johnstone Thitiri; Moses Ngari; Laura Mwalekwa; Victor Bandika; Rehema Ali; Fauzat Hamid; Betty Owor; Neema Mturi; Isabel Potani; Benjamin Allubha; Anneke C Muller Kobold; Rosalie H Bartels; Christian J Versloot; Marjon Feenstra; Deborah A van den Brink; Patrick F van Rheenen; Marko Kerac; Celine Bourdon; James A Berkley
Journal:  PLoS Med       Date:  2019-02-26       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.